Ind-Swift Limited (NSE:INDSWFTLTD)
India · Delayed Price · Currency is INR 15.96
-0.40 (-2.44%)
Aug 6, 2025, 3:29 PM IST
Ind-Swift Market Cap
Ind-Swift has a market cap or net worth of 892.09 million as of August 6, 2025. Its market cap has decreased by -20.59% in one year.
Market Cap
892.09M
Enterprise Value
8.93B
Revenue
5.15B
Ranking
n/a
PE Ratio
0.31
Stock Price
15.96
Market Cap Chart
Since January 10, 2002, Ind-Swift's market cap has increased from 246.56M to 892.09M, an increase of 261.82%. That is a compound annual growth rate of 5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 892.09M | -49.86% |
| Dec 31, 2024 | 1.78B | 83.72% |
| Dec 29, 2023 | 968.46M | 41.12% |
| Dec 30, 2022 | 686.27M | -0.39% |
| Dec 31, 2021 | 688.97M | 218.00% |
| Dec 28, 2020 | 216.66M | 23.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Mankind Pharma | 1,059.19B |
| Apollo Hospitals Enterprise | 1,057.03B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |